Translational Development Acquisition Corp. (TDACU) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 31Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−342.2x

Market Cap

$323.04M

MomentumView details →

1D Return

−2.31%

YTD Return

+20.40%

RSI (14)

63.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−342.2x

Market Cap

$323.04M

RSI (14)

63.2

MomentumView details →

1D Return

−2.31%

YTD Return

+20.40%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

3.63%

ROA (TTM)

3.50%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+3611.18%

FCF YoY

—

Revenue CAGR 3Y

−100.00%

EPS CAGR 3Y

+2383.95%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

0.07x

Quick Ratio

0.07x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

−415611.00

Net Income (TTM)

5.54M

Op. CF (TTM)

6.10M

Latest newsMore news →

ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.39d ago

Translational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.61d ago

Similar companies

Crane Harbor Acquistion Corp. UnitsCHACU GP-Act III Acquisition Corp.GPATU Cal Redwood Acquisition Corp. Class A Ordinary SharesCRAQ Perimeter Acquisition Corp. I Class A Ordinary SharesPMTR Aldel Financial II Inc.ALDF Willow Lane Acquisition Corp.WLAC Find similar companies →

Latest newsMore news →

ProLogium and Translational Development Acquisition Corp. announced a $50 million committed primary capital investment from existing ProLogium shareholders to support their business combination that will make ProLogium a publicly listed company.39d ago Translational Development Acquisition Company announced that ProLogium has filed an F-4 with the SEC as part of their planned de-SPAC merger.61d ago